Institut Cancérologique de l'Ouest

The Institut Cancérologique de l'Ouest (ICO) is a leading French comprehensive cancer center and a prominent member of the Unicancer network. Operating across two primary sites in Nantes (Saint-Herblain) and Angers, the institute provides integrated oncology services including prevention, diagnosis, treatment, and supportive care. ICO is a major European hub for clinical research, participating in numerous Phase I, II, and III clinical trials in partnership with global pharmaceutical and biotech companies. The organization is particularly recognized for its expertise in radiotherapy, nuclear medicine, and translational research, specifically in breast and urological cancers. As a non-profit private health establishment of public interest (ESPIC), it combines high-volume clinical practice with academic teaching and innovative medical research.